张倩, 邓登豪, 刘军, 陈炜炜, 陈娟, 陈超伍. 非甾体类抗炎药预防经内镜逆行胰胆管造影术后胰腺炎的研究进展. 世界华人消化杂志 2022; 30(4): 198-203 [DOI: 10.11569/wcjd.v30.i4.198]
Reader's ID:
03243987
Submitted on:
March 18, 2022, 07:29
Reader Expertise:
Reader’s expertise on the topic of the manuscript
Conflicts-of-Interest Statement:
Does the reader have a conflict of interest?
Reader Comment Standards for Published Articles:
Scientific Quality:
The overall quality of the manuscript, based on the above-listed criteria, should be evaluated and classified according to the following five categories
Language Quality:
Language quality (style, grammar, and spelling) should be evaluated and classified according to the following five categories.
Reader Comments:
本文作者就非甾体类抗炎药(NSAIDs)在预防经内镜逆行胰胆管造影术后胰腺炎(PEP)中的应用标准尚不统一. 所以作者综述了NSAIDs不同的药物类型、给药途径、给药时机、给药剂量、联合其它药物以及对不同风险分层人群的PEP预防效果的最新研究进展, 结合临床，选题独特，有一定临床参考价值